COVID-19 vaccine attitude and related factors in a public institution personnel

Abstract

Objective: Vaccine hesitancy and vaccine refusal are an important public health problem and limits the response to the pandemic. In this study, it was aimed to examine COVID-19 vaccine attitude and related factors among a public ınstitution workers.

Methods: This research is a descriptive cross-sectional study and was conducted in a public institution in September 2021. The universe of the study consists of all employees (2374 people) in this instituti¬on and 1908 people (80.4%) participated in the study. A questionnaire of 31 questions developed by the researchers was used as a data collection tool. Descriptive statistics, chi-square and logistic regres¬sion tests were used in the analysis of the data. The analyses were performed using SPSS23.0 program and the significance level was accepted as p<0.05.

Results: 71.0% (n=1287) of the participants were male and the mean age was 40.7% (95%, 40.3- 41.1%). Of those who were not vaccinated (14.0%, n=256), 6.6% were undecided about vaccination (n=121), while 0.5% (n=10) were anti-vaccine. The frequency of COVID-19 vaccination increases with being a woman, older age, the presence of chronic diseases in the participants themselves and their household, the fact that their children have received their childhood vaccinations in full, that they and their household do not have a history of COVID-19, that they are worried about experiencing serious health problems due to COVID-19 and that they are afraid of death, and that all other individuals in the household have been vaccinated.

Conclusion: It is thought that reaching out to individuals one-on-one and providing accurate and adequate information about the safety and effectiveness of vaccines will make significant contributi¬ons to increasing the success of the COVID-19 vaccination program.

Keywords

• COVID-19
• Vaccine Hesitancy
• Anti-Vaccination
• COVID-19 Vaccine

Bir kamu kurumu çalışanlarında COVID-19 aşı tutumu ve ilişkili etmenler

Abstract

Amaç: Aşı kararsızlığı ve aşı karşıtlığı pandemi ile mücadelede önemli bir halk sağlığı sorunudur. Çalışmanın amacı; bir kamu kurumu çalışanlarında COVID-19 aşı tutumu ve ilişkili etmenlerin belirlenmesidir.

Yöntem: Tanımlayıcı kesitsel tipte olan araştırma, Eylül 2021’de bir kamu kurumunda yapılmıştır. Çalışmanın evrenini bu kurumdaki tüm çalışanlar (2374 kişi) oluşturmaktadır ve çalışmaya 1908 kişi (%80.4) katılmıştır. Veri toplama aracı olarak, araştırmacılar tarafından geliştirilen 31 soruluk bir anket formu kullanılmıştır. Verilerin analizinde tanımlayıcı istatistikler, ki-kare ve lojistik regresyon testleri kullanılmıştır. Analizler SPSS 23.0 programı kullanılarak yapılmış ve anlamlılık düzeyi p<0.05 olarak kabul edilmiştir.

Bulgular: Katılımcıların %71.0’ı (n=1287) erkektir ve yaş ortalaması 40.7 yıldır (%95GA:40.3- 41.1). Aşı olmayanların (%14.0, n=256) %6.6’sı aşı ile ilgili kararsızken (n=121) , %0.5’i (n=10) aşı karşıtıdır. COVID-19 aşısı olma sıklığını; kadın olmak, ileri yaş, katılımcıların kendisinde ve hanesinde kronik hastalık varlığı, çocuklarının çocukluk çağı aşılarını tam yaptırmaları, kendisi ve hanesinde COVID-19 öyküsünün olmaması, COVID-19 nedeniyle ciddi sağlık sorunu yaşama endişesi ve ölüm korkusu olması ve hanedeki diğer bireylerin hepsinin aşı olmuş olması artırmaktadır.

Sonuç: Aşıların güvenliği ve etkililiği konusunda bireylere ulaşarak doğru ve yeterli bilgi vermenin, COVID-19 aşılama programının başarısını artırmada önemli katkılar sağlayacağı düşünülmektedir.

Keywords

• COVID-19
• aşı karşıtlığı
• COVID-19 aşısı.
• Aşı Tereddüdü

References

1. Ehreth J. The value of vaccination: a global perspective. Vaccine. 2003 Oct 1;21(27– 30):4105–17.
2. WHO. Vaccines and immunization: What is vaccination? [online]. Available at: https://www.who.int/health-topics/ vaccines-and-immunization#tab=tab_1. Accessed April 7,2022.
3. Haque A, Pant AB. Efforts at COVID-19 Vaccine Development: Challenges and Successes. Vaccines. 2020 Dec;8(4):1–16.
4. Kata A. A postmodern Pandora’s box: anti-vaccination misinformation on the Internet. Vaccine. 2010 Feb;28(7):1709– 16.
5. WHO. Vaccine Hesitancy: what it means and what we need to know in order to tackle it [online]. Available at: https:// www.who.int/immunization/research/ forums_and_initiatives/1_RButler_ VH_Threat_Child_Health_gvirf16.pdf. Accessed October 4,2021.
6. WHO. Ten threats to global health in 2019 [online]. Available at: https://www. who.int/vietnam/news/feature-stories/ detail/ten-threats-to-global-health-in-2019. Accessed October 4,2021.
7. WHO. WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [online]. Available at: https://covid19. who.int/%0Ahttps://covid19.who. int/%0Ahttps://covid19.who.int/region/ searo/country/bd. Accessed April 7,2022.
8. Wu SC. Progress and Concept for COVID-19 Vaccine Development. Biotechnol J. 2020 Jun;15(6):2000147.

9. Feleszko W, Lewulis P, Czarnecki A, Waszkiewicz P. Flattening the Curve of COVID-19 Vaccine Rejection—An International Overview. Vaccines. 2021 Jan;9(1):1–8.
10. Our World in Data. Coronavirus (COVID-19) Vaccinations - Our World in Data [online]. Available at: https://ourworldindata.org/ covid-vaccinations. Accessed February 28,2022.
11. Lin C, Tu P, Beitsch LM. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines. 2021 Dec;9(1):1–32.
12. Morning Consult. National Tracking Poll #200409 April 03-05, 2020 Crosstabulation Results [online]. Available at: https://assets.morningconsult. com/wp-uploads/2020/04/200409_ crosstabs_CORONAVIRUS_CONTENT_ Adults_v4_JB-1.pdf. Accessed February 28,2022.
13. Galvin G. 48% of US Adults Now Say They’d Get a COVID-19 Vaccine, a New Low [online]. Washington, DC: Morning Consult; 2020. Available at: https:// morningconsult.com/2020/10/12/48-of-u-s-adults-now-say-theyd-get-a-covid-19- vaccine-a-new-low/. Accessed February 28,2022.
14. Lazarus J V., Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2020 272. 2020 Oct;27(2):225–8.
15. Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Heal Econ. 2020 Sep;21(7):977–82.
16. Daly M, Jones A, Robinson E. Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021. JAMA. 2021 Jun;325(23):2397–9.
17. Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Heal. 2021 Apr;6(4):210–21.
18. Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, et al. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines. 2021 Mar 22;9(3):300.
19. Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020;1–3.
20. Guidry JPD, Laestadius LI, Vraga EK, Miller CA, Perrin PB, Burton CW, et al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021 Feb;49(2):137–42.
21. Ward JK, Alleaume C, Peretti-Watel P, Seror V, Cortaredona S, Launay O, et al. The French public’s attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc Sci Med. 2020 Nov;265:113414.
22. Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ, Ayre J, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021 Mar;21(3):318–9.
23. Our World in Data. Attitudes to COVID-19 vaccinations - Our World in Data [online]. Available at: https://ourworldindata.org/ attitudes-to-covid-vaccinations. Accessed February 28,2022.
24. Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020 Jun;80(6):14–8.
25. Bish A, Michie S. Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. Br J Health Psychol. 2010 Nov;15(4):797– 824.
26. Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med. 2021 Feb;270:113684.
27. Akarsu B, Canbay Özdemir D, Ayhan Baser D, Aksoy H, Fidancı İ, Cankurtaran M. While studies on COVID-19 vaccine is ongoing, the public’s thoughts and attitudes to the future COVID-19 vaccine. Int J Clin Pract. 2021 Apr;75(4):13891.
28. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Articles Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.
29. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr;323(16):1545–6.
30. Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, et al. Factors Associated with US Adults’ Likelihood of Accepting COVID-19 Vaccination. JAMA Netw. 2020;3(10):2025594.
31. Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, Uğurlu S, et al. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int. 2021 Jun;41(6):1105–14.
32. Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021 Aug 1;97:107724.
33. Marti M, De Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns. PLoS One. 2017 Mar 1;12(3):0172310.
34. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults. Ann Intern Med. 2020 Dec 15;173(12):964–73.
35. Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, et al. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines. 2020 Oct;8(4):582
36. WHO. Coronavirus disease (COVID-19): Vaccines safety [online]. Available at: https://www.who.int/news-room/questions-and-answers/item/ coronavirus-disease-(covid-19)-vaccines-safety. Accessed March 1,2022.
37. Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020 May;52(5):737.